Search for: "Sanofi"
Results 61 - 80
of 1,187
Sort by Relevance
|
Sort by Date
2 Oct 2023, 9:32 pm
By Kevin E. [read post]
29 Sep 2023, 2:52 am
Amgen v Sanofi, IPKat). [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
20 Sep 2023, 9:39 am
Sanofi, 598 U.S. 594 (2023). [read post]
10 Sep 2023, 9:15 am
Sanofi, 143 S. [read post]
10 Sep 2023, 9:15 am
Sanofi, 143 S. [read post]
26 Aug 2023, 9:16 am
Settlement As was pointed out in an article of EIP Amar, ‘many of the parties involved in (…) initial infringement actions are pairings familiar from litigation already being fought in UK, Germany or US, such as Edwards Life Sciences against Meril, Ocado against Autostore and Amgen against Sanofi / Regeneron’. [read post]
7 Aug 2023, 6:01 am
., and Sanofi-Aventis U.S. [read post]
2 Aug 2023, 11:28 am
Sanofi. [read post]
2 Aug 2023, 11:05 am
Sanofi further argued that the Board improperly shifted the burden of persuasion from Mylan to prove that the challenged claims were unpatentable to Sanofi to defend the claims of the ’614 patent as patentable. [read post]
31 Jul 2023, 1:18 am
Interestingly, the US Supreme Court in the recent decision on enablement in Amgen v Sanofi also took great pains to emphasise that the law of enablement of broadly claimed inventions was originally derived from, and continues to apply, to the mechanical field (IPKat). [read post]
28 Jul 2023, 8:26 am
However, it follows a similar action filed in May by Lake County, Illinois in which the County accuses Eli Lilly, Novo Nordisk, Sanofi, Express Scripts, and OptumRx are accused of violating the state's Consumer Fraud Act and the RICO Act. [read post]
23 Jul 2023, 9:53 pm
Sanofi, where the Supreme Court addressed the enablement requirement for patent claims directed to antibodies.... [read post]
20 Jul 2023, 3:44 am
This is the second post considering the Court of Appeal decision on plausibility in Sandoz v BMS ([2023] EWCA Civ 472), in the context of the Enlarged Board of Appeal decision in G 2/21. [read post]
20 Jul 2023, 1:42 am
This Kat took the enforced confinement of a rainy summer weekend to finally delve deeper into one of the key patent decisions from the UK courts this year. [read post]
15 Jul 2023, 6:00 am
Sanofi NG 598/2 23 5/18/23 21-869 Andy Warhol Foundation for Visual Arts, Inc. v. [read post]
15 Jul 2023, 6:00 am
Sanofi NG 598/2 23 5/18/23 21-869 Andy Warhol Foundation for Visual Arts, Inc. v. [read post]
13 Jul 2023, 5:01 am
Sanofi. [read post]